June 4, 2026 Phase 1 Trial of AAV8-Mediated LDL Receptor Gene Therapy for Familial Hypercholesterolemia
June 3, 2026 MTC01 Biotherapeutic Shows Comparable Efficacy to Fecal Microbiota Transplant in Phase 1b Trial
